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Flow biocatalysis 101: design, development and
applications
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The integration of enzyme-catalyzed reactions in flow systems has been boosted during the last few years.
Nowadays, biocatalysis is officially recognized as a tool to increase reaction specificity and sustainability,
however applications are sometimes characterized by low productivity. A logical step to improve the
performance of biocatalytic reactions is represented by the combination of enzymes and flow facilities.
This tutorial review aims at introducing the key concepts of flow biocatalysis, guiding the reader through its
advantages and highlighting the current trends in the field to encourage innovative applications of enzymes
in flow reactors. Experimental cases are also presented and discussed as a troubleshooting guide for
development of flow biocatalytic processes.
1. Introduction
1.1 Process in continuous: flow chemistry
Cost-efficiency, in any process, is the major driving force of
innovation but nowadays, other factors must also be
considered. Public awareness on the importance to minimize
the impact of our ever-growing product demand on the
environment has reached a turning point during the last two
decades. Consequently, not only the costs are considered, but
also the process sustainability and compliance with the green
chemistry principles.1,2 It is not a coincidence that for more
than 10 years now, continuous processing has found its niche
in chemical production. This technology was already used for
petrochemical and bulk chemical production, for example,
but it is not as common in fine chemicals and pharma
industry.3 It is through the synergy between green process
development and the design of an efficient flow-based
approach that continuous biocatalytic processing and
production, and its benefits compared to batch-based
strategies can be truly implemented.4
Batch processes are commonly used in pharmaceutical
and synthetic chemistry due to their flexible production
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planning, fast implementation as well as process and product
traceability. Although companies favor batch processes due
to the availability of sunk capital for this technique and
accumulated knowledge, they require significant investment
in material, large storage facilities for chemicals, solvents
and, noteworthy, process intermediates. Also, the scalability
is never straightforward as heat and mass transfer are a
challenge.
In contrast, continuous flow setups normally require
smaller equipment footprint and their automation reduces
the need for human manipulation. As per the scalability,
while scale up approaches would face the same heat and
mass transfer issues, scale out approaches, (connecting
different flow reactors in series or parallel) are a good
alternative. Initially, microflow scale out gained attention but
there has been a shift in the later years towards meso-
reactors as their productivity matches better with industrial
needs. Continuous flow strategies are also safer than their
batch counterparts, allowing the use of conditions (such as
pressure, temperature or reactivities) that would be nearly
impossible to apply safely in batch. In addition, continuous
operations can improve the cost-efficiency and sustainability
through process intensification and feedback loop strategies
(increased yields and decreased solvent/energy waste)
opening the possibility of continuous monitoring. These are
the fundamental principles that drive the expansion of flow
chemistry.5
Early on, flow chemistry was applied in the field of
organometallic chemistry as a strategy for heterogeneous
catalysis to shorten reaction times or when hazardous
compounds were utilized. More recently, scientists are taking
advantage of flow chemistry not only in ‘process
intensification’ but also in ‘discovery’. As an example,
packed-bed reactors (PBR) can provide information about the
performance of a new catalyst while scalability and stability
are tested at a laboratory scale with very high catalyst to
substrate ratios. In this way, emerging and interconnected
scientific disciplines have been developed through innovative
approaches which integrate flow technologies in chemistry,
biotechnology, biomedicine, and photocatalysis among
others.
The core of flow reactors is very simple: it requires pumps
to feed solvents and reagents, different size channels, and
the vessel where the reaction takes place. Besides those
essential elements, several types of junctions, mixers, and
pressure regulators are typically part of flow machines.
Temperature controllers can be also added. In more
advanced set-ups, in-line separation devices (extractors),
product purification accessories (scavenger columns), as well
as gas, UV-light or microwave suppliers complement the flow
process design. Even analytical components (LC-MS, GC-MS,
spectrophotometers, bench-top NMR) may be connected to
the continuous flow line to provide real-time reaction
monitoring. Such a set-up may seem of a high complexity but
there is a broad variety of customized flow reactors which are
commercially available and can cater for the specific need of
a research lab in both academia and industry (Vapourtec Ltd,
Ehrfeld, Syrris, AM Technology, Corning, ThalesNano
Nanotechnology Inc., Advion Inc., Future Chemistry Holding
BV, YMC Co. Ltd, Accendo, Uniqsis Ltd and Chemtrix BV).
Nevertheless, fabrication of DIY-equipment is a customary
trend in many labs around the world, especially when
affordability or availability become an issue. Interestingly,
3D-printers are expanding the possibilities of tailored flow
chemistry reactors for many researchers in the field.6
1.2 What is biocatalysis?
Biocatalysis, is defined as the use of whole cells or their
components as catalysts for a certain chemical reaction.
Although sometimes biocatalysis is perceived as something
new, it comes from very ancient times. Our group recently
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published an almost unique review on the history of enzymes
and their affirmation as powerful synthetic tools.7
The use of whole cells, also referred as fermentations,
present the major drawback of possible cross-reactivity with
other metabolites and naturally expressed enzymes. In
addition, cell-wall permeability may affect the substrate
diffusion hampering its transformation, while its stability
may lead to cell-lysis and loss of compartimentalization.8
As an alternative, purified enzymes can be used as
catalysts, which solves in one shot the two problems stated
before: diffusion and side-reactivity. In this case, the main
drawbacks are the costs for the preparation of the pure
catalyst, its stability and reusability. Enzyme immobilization
can however come to the rescue and significantly reduce
these limitations.9–11 In fact, once the enzymes are
immobilized, their removal from the reaction bulk, reuse,
and incorporation in continuous-mode reactors is straight-
forward. This, greatly simplifies the work-up, reducing the
produced waste and impacting the cost-effectiveness of the
process.
Biocatalyzed reactions in flow can benefit from improved
productivity thanks to enhanced mass transfer and better
control of the reaction parameters. Better process control
makes the bioreaction more efficient minimizing waste and
energy consumption. In addition, the absence of harsh
mixing prolongs the biocatalysts lifetime, thus reducing the
costs associated with their preparation.
In this review, our intention is to stimulate the interest of
chemists and biochemists so that they may expand their
toolbox and knowledge and embrace flow biocatalysis, which
has the potential to become a widespread tool to move
chemical transformation to a more sustainable, productive
and cost-efficient way.
It must be noted early on that not all processes are (yet)
suitable for flow, but when flow is an option it may offer not
just an alternative approach, but a system with benefits
beyond expectations.
2. Terminology
As any other field, flow biocatalysis uses a specific
terminology that might seem a highly technical jargon for a
newcomer in this area and be off-putting. For this reason,
the parameters used to define and evaluate performance and
efficiency of flow biocatalysis are described in this section. In
addition, it will help specialists to standardize their results
and transmit the content more effectively.
2.1 Flow chemistry parameters
Chemistry reactions for the preparation of valuable
commercial products need to be operated in an efficient way
with respect to the starting reagents, catalyst and equipment,
in a reactor compatible with the characteristics of the
reaction:
Reaction yield ¼ mol of product
mol of substrate
Catalyst productivity ¼ g of product
g of substrate
Volumetric productivity ¼ g of product
L·h
The schematic representation of a flow process and the
typical equipment are reported in Fig. 1 and 2. It consists of
pumps: HPLC, syringe, peristaltic or gear centrifugal pumps
used to deliver solvents and reagents in a controlled and
reproducible way; loops: for the introduction of small volume
of reagents; mixing tubes: first point of mixing between
different reagents; reactors typically temperature controlled:
mesoreactors (coils or column reactors), microreactors
(chips); back pressure regulator (BPR): controlling the
pressure of the whole system; downstream units: work-up
operations, purifications and analysis.
Miniaturization for flow reactors is associated with devices
typically designed with channels or tubes with different
internal diameters (i.d.) from μm (microreactors) to mm
(mesoreactors) (Fig. 1 and 2). The first ones, typically
microfluidic reactors, present an internal diameter <500 μm
and a volume in the μL range. They are classified as chips or
microtube devices where the reaction environment is a
microchannel made of metal, glass or plastic. Among the
advantages, effective heat/mass transfer and temperature
control are noteworthy. On the other hand, mixing is limited
by diffusion while high pressure drops (decreasing of
pressure between the 2 lengths of the channel due to
unbalanced pressure and viscosity forces) and channel
obstruction may occur, especially in the presence of
suspensions.
Mesoreactors have an internal diameter >500 μm to
several mm, and a volume in the mL range. They present
high flow capability and low pressure drops but less efficient
heat transfer. While microreactors are characterized by
laminar flow, mesoreactors exceeding 1 mm can present a
turbulent flow, especially at high flow rates. Between 500 μm
and 1 mm i.d. the type of flow generated depends on the flow
conditions. To overcome issues related to mixing efficiency,
mesoreactors are available with different designs; coil
reactors providing homogeneous mixing are preferable for
liquid–liquid interaction while column reactors are typically
packed with immobilized catalysts.
To compare the performance of different
biotransformations or of the same biotransformation in
different flow reaction conditions, key parameters need to be
properly reported:
- Residence time: time (min) the reagents take to go across
the reactor (reaction time).
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- Biocatalyst loading: amount of biocatalyst added to the
reactor (for immobilized biocatalysts is better to specify also
the matrix loading: mgbiocatalyst gmatrix
−1).
- Specific biocatalyst activity: U mgenzyme
−1 before the
beginning of the process.
- Biocatalyst activity: specific activity per biocatalyst
loading expressed per gram of matrix (U gmatrix
−1) before
starting the reaction.
- Reagent/substrate concentration: concentration of the
reagent/substrate entering the reactor.
- Reactor size: available reactor volume (channel size or
void volume need also to be reported).
- Bioreactor productivity: space–time yield (STY)
normalized to the available reactor volume (product quantity
(mol)/catalyst volume (L) time (h)).
- Biocatalyst productivity: g of product synthesized per g of
biocatalyst employed in the flow reaction.
- Bioreactor stability: biocatalyst activity over time.
Reaction rate of a flow reaction is usually calculated as
reported in the following equation:
rflow ¼ P½ · fg biocatalyst
[P]: product concentration expressed as mmol mL−1, f: flow
rate expressed as mL min−1, g biocatalyst: the amount of
enzyme expressed in g added to the reactor (it could be
replaced by the activity in U).
2.2 Metrics of sustainability
The contribution of flow biocatalysis to more eco-friendly
synthetic processes, promotes the need for the evaluation of
its “greenness” to be able to compare with both chemical
catalysis and batch biocatalytic processes. Atom economy,
the E factor and process mass intensity (PMI) are the most
widely used metrics in green chemistry.12
Atom economy (AE) is a theoretical value very useful as a
prediction tool to rapidly assess the waste that will be
produced within individual steps. AE is expressed as a
percentage and calculated as follows, where MW is the
molecular weight:
AE %ð Þ ¼ MW of the desired product
sum of the MW of the of starting materials
AE is the simplest metric of sustainability since only the
substances produced in the stoichiometric equation are
considered, dismissing solvents and additional chemicals.
However, the application of AE can be a misleading metric
when very heavy atoms are involved, and it should not be
used in those cases.
The E factor is an experimental parameter that refers to
the actual waste produced and normalized to the product:
Fig. 1 Schematic representation of a flow reactor configuration involving mesoreactors (A) or microreactors (B). Figure adapted from Tamborini
et al.59
Fig. 2 Flow equipment and representation.
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E factor ¼ kg of waste
kg of product
Unlike AE, the E factor also contemplates the auxiliary
components and solvents, and it can be applied to multi-step
procedures, offering a better assessment of the complete
process. The lower the E factor is, the more sustainable the
catalytic process, with zero being the ideal E factor.
Interestingly, lower E factors often agree with lower
manufacturing costs due to reduced input of starting
materials.
Another mass-based metrics is the process mass intensity
(PMI) which is tracked during the lifecycle of pharmaceutical
compounds.13 To evaluate the PMI, the roundtable tool
developed by the ACS Green Chemistry Institute
Pharmaceutical can be used.14
3. Key enabling technologies for
enzyme stability
Enzymes are designed by nature to fulfil the requirements of
life sustainment. Clearly, the natural environment is often
quite different from the industrial conditions required for
large-scale processes. An ideal biocatalyst for industrial
applications should be stable for a long period of time,
resistant to harsh (non-physiological) reaction conditions,
eco-friendly, and economically viable. Several technologies
such as enzyme immobilization, protein engineering, and
computational tools are employed during the design and
development of biocatalysts to achieve the highest
efficiency.15
3.1 Enzyme immobilization
During the immobilization process, enzyme molecules are
typically attached to, or confined into, solid materials. The
immobilized enzymes acquired advantages in terms of
stability against inactivating agents (i.e. temperature, pH,
organic solvents), separation of the products from the
biocatalyst, reuse/recycle of the biocatalyst for a new reaction,
and improved reaction rates.16 These features are paramount
for the integration of enzymes in flow reactors.11 However,
no universal immobilization methodology has yet been
proven suitable for any given enzymes.10 Therefore, enzyme
immobilization is still an empirical process trying to achieve
the best equilibrium between activity and stability of the
biocatalyst of interest.17
Two main immobilization strategies are adopted in flow
biocatalysis: attachment of enzymes on the reactor wall or
immobilization onto a solid carrier material suitable to be
integrated into a PBR (Fig. 3). Enzyme immobilization in
wall-coated reactors is often applied for microfluidic systems
where solid carriers could cause clogging issues.18
Experimentally, the enzyme solution in the appropriate buffer
is incubated with the solid support under gentle shaking for
a certain time (usually, hours) until all the offered protein
has been immobilized or the maximum binding capacity has
been reached.
Enzyme immobilization can be performed by either
reversible or irreversible interactions. We start testing
irreversible immobilization techniques which offer a higher
stability and avoid leaching of the enzyme while operating
flow reactors. These advantages increase the operational
lifespan of the biocatalysts promoting one of the key goals of
flow biocatalysis: a high accumulated STY relative to the
amount of enzyme used. Enzymes can be irreversibly
immobilized on a carrier material by forming covalent bonds
between selected residues of the protein and the functional
groups of the carrier surface. Unfortunately, irreversible
immobilization strategies compromise the recyclability of the
reactor/carrier when the enzyme activity tends to zero.
Alternatively, cross-linked enzyme aggregates (CLEAs) are a
carrier-free immobilization technique which relies on the
irreversible binding of enzymes mediated by crosslinking
agents such as glutaraldehyde and biominerals.16 Yet, the
mechanical stability, the mass transfer issues, and the wide
distribution of particle size of the CLEAs limit their use in
flow biocatalysis. Moreover, irreversible immobilization
promotes sometimes a dramatic loss of enzyme activity upon
immobilization.
As a reversible immobilization technique, enzyme
adsorption (i.e. through ionic and hydrophobic interactions)
onto the carrier usually maintains the activity of the
immobilized enzyme. Another reversible immobilization
protocol is accomplished by genetic fusion of peptide tags
(i.e. (6×) His-tag, Halo-tag, Spy-tag) to the enzymes, enabling
their attachment to either a carrier or a reactor wall through
affinity interactions. This technique allows the purification
and specific immobilization of the enzyme in just one step as
well as the control of the enzyme orientation. Additionally,
physical entrapment/encapsulation is used by covering the
enzymes with polymers or sol–gel matrices which result into
a milder distortion of the enzyme structure. All these
Fig. 3 Scheme of the enzyme immobilization strategies in flow
biocatalysis. An example of each type of interaction is also depicted:
ionic interaction (adsorption); metal coordination bond (affinity);
disulfide bond (covalent reversible); sol–gel matrix (encapsulation);
C–N bond (covalent irreversible); CLEAs (crosslinking). Flow reactor:
, enzyme: , carrier: .
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reversible procedures can be reverted, which allow the
recycling and reuse of the costly carriers once the enzyme is
inactive by reloading it with fresh enzyme. Nevertheless, the
stability of the immobilized enzymes is often pretty low due
to the lack of rigidification of the enzyme structure and
leaching of the enzyme while working in continuous flow
conditions.
The most used materials for enzyme immobilization are
either methacrylate or agarose microbeads. From an
industrial perspective, methacrylate is a robust premade
support with high resistance to flow conditions such as high
pressure and presence of solvents. Agarose is a more
hydrophilic support which is chosen to tackle issues of poor
enzyme activity and stickiness of substrates/products on
hydrophobic supports. Other supports like silica particles,
lignin, magnetic nanoparticles, etc. can be used for
integration of immobilized enzymes in flow reactors. In case
of enzyme immobilization on microreactor walls, polymeric
tubing (i.e. polytetrafluoroethylene, polystyrene,
polydimethylsiloxane) are commercially available.9
3.2 Protein engineering and computational tools
Evolution of native enzymes to become efficient industrial
biocatalysts is addressed by protein engineering, often aided
by computational tools (i.e. Chimera, Pymol). In general
terms, there are two approaches to improve the functional
properties of enzymes: directed evolution and rational
design.
Directed evolution rely on random combinations of
mutations in the protein sequence that may potentially
generate improved enzymes.19 While the probability of
success of this very time-consuming strategy is quite low, it is
an appealing option when no structural information of the
enzyme or no prior knowledge of the catalytic mechanism is
available. The rational design depends on the analysis of the
sequence and the structure of proteins to further introduce
mutations in specific positions.20 For these reasons, a
combined strategy using rational design and directed
evolution is usually the best approach.
Nowadays, the increasing number of protein libraries and
in silico tools such as protein modelling and dynamic
simulations is speeding up the optimization and
development of process-specific biocatalysts.21 Moreover, new
computational tools that take advantage of bioinformatic
analysis specifically for protein immobilization (i.e. CapiPy)22
are opening new possibilities to apply semi-rational
approaches to enhance the performance of immobilized
biocatalysts.
4. A never-ending reaction: versatility,
combination and automation
4.1 Cofactor recycling in flow mode
Most of the examples we find in flow biocatalysis are single
step transformations, but this technology can also be applied
for multi-enzyme-mediated cascade reactions. Very recently,
John M. Woodley discussed the hurdles present in the multi-
step design and implementation of such enzymatic cascades
for industry.23 Due to the versatility and
compartmentalization of flow reactors some of the
mentioned problems can indeed be tackled by continuous
operations. Initial examples about immobilized enzymes in
continuous mode, where limited to the use of packed-bed
reactors containing only the biocatalyst for a single
biotransformation, facing since the beginning the issue of
expensive cofactor requirement especially for redox enzymes.
Further research allowed for the development of different
strategies for flow mode cofactor recycling. For example, the
continuous addition of a co-substrate (e.g., EtOH) as a
sacrificing substrate to recycle the cofactor was reported by
Contente & Paradisi in cascades involving the reduction of
aldehydes into the corresponding alcohols through the horse
liver alcohol dehydrogenase (HLADH).24 This technique
allows for the use of only one biocatalyst able to carry out
both the redox reaction and the cofactor regeneration,
positively impacting on process economy. On the other hand,
the required co-substrate large excess to push the
equilibrium towards product formation, can affect the
biocatalyst performance. The enhanced catalyst stability
achieved through the combination of immobilization
techniques and flow facilities deeply mitigated this
phenomenon. Other strategies involved the (co)-
immobilization of two different enzymes: the principal one
for the main reaction and the ancillary enzyme for the
cofactor recycling. When two or more biocatalysts are
simultaneously co-immobilized onto the same support, a
high catalyst compatibility is required. When this condition
is not achievable, individual biocatalyst immobilization
followed by mixing of the resins (mixed-bed reactor),25 or by
sequential immobilization onto the same support are
pursued. A further implementation of the latter technique
was achieved by the group of Prof. López-Gallego. Through a
spatial organized immobilization involving also the co-
factors, they gave rise to self-sufficient systems, increasing
the process cost-efficiency and avoiding the addition of
exogenous expensive molecules.26
4.2 Telescoped reactions
While in batch the use of sequential reactions is tedious and
requires manual adjustment as well as work-up and
purification between the different steps, in flow, they can be
combined in a modular way. Theoretically, if a sequence of
stepwise reactions can be set up using the same solvent or
simply applying an exchanging solvent mechanism, the
optimized reactions could be processed in tandem. In this
way the reaction mixture for the first step becomes the
reagent for the next one creating a telescoped sequence. This
versatility allows cascade design using different reaction
conditions, as some flow system allows different reactors to
be maintained in different working conditions; temperature
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can be individually controlled as well as pH, ionic strength,
etc. For example, pH can be changed by the addition of an
acid or a base, a second reagent can be added between the
reactors, and concentrations modulated by adding a diluting
factor. If on one side this ideal scenario is not so easy to
achieve due to the need to quench reactions, work-up
intermediates, and consequently purify the stream between
the different transformations, on the other side it is possible
to integrate other enabling technologies to obtain in-line
filtration, extraction, distillation, and purification to
maintain a continuous flowing sequence. All these steps can
be automated through dedicated connected software. With a
careful process design, continuous flow allows a fine control
with minimum manual operator intervention and
manipulation.
4.3 Downstream unit operations and automation
The concept of “automated flow” in organic chemistry was
extensively developed by Prof. Ley and his research group in
order to obtain more efficient, sustainable and innovative
processes.
One of the main aspects concerns work-up procedures
and purification steps, which are often considered a
bottleneck in continuous synthesis. Solid supported reagents
have widely dominated product purification in flow multi-
step processes. They mainly consist in reactive species
associated with heterogeneous support material.27 Ideally,
the use of such reagents should trap the impurities from the
flow stream giving a pure product without any traditional
work-up procedure (i.e. chromatography, crystallization,
distillation) fulfilling either electrostatic or covalent
interactions between the solid matrix and the undesired
species. Due to their universal application, a wide range of
functionalized scavenger columns are now available on the
market. However, while these materials are extensively used,
they present some limitations, especially in terms of cost and
reduced lifetime. Typically, solid-supported reagents cannot
be recycled continuously requiring an interruption of the flow
sequence. This is the case for example of catch and release
strategies through ion-exchange resins where the addition of
diluted solutions of acids or bases let the recovery of the
trapped molecules as salt form.28,29 Moreover, increasing the
amount of the scavenger during the reaction scale-up, leads
to undesired scale-depended dispersion/diffusion
phenomena. Consequently, a thorough evaluation of the flow
design is necessary before using them. Despite the
development of numerous tools to increase the automation
of work-up procedures considered time- and cost-consuming,
and to reduce the environmental burden, continuous
synthesis is usually followed by “discontinuous” purification
because the limited number of available options.30,31 Often
chemists necessitate to resort to old fashion batch
chromatography methods for the separation of complex
mixture of products, particularly when they present same
functional groups.32 So far, high purity can be achieved by in-
line procedures through multi-column chromatography,33 or
simulated moving bed (SMB) chromatography.34,35 O'Brien
and coworkers36 developed the first example of in-line SMB
(simulated moving-bed) chromatography for the continuous
production of a clean product. This concept, born in the 60s
is still used in many industrial applications (e.g.,
petrochemical, food, and pharmaceutical industries) and
consist basically in the simulation of the movement of the
stationary phase in the opposite direction of the fluid to
achieve a counter-current flow, rather than flowing fluids
through a static bed. While SMB chromatography has a great
potential for the purification of different organic compounds,
it showed also several drawbacks in terms of costs (high
initial investment and maintenance related expenses) as well
as higher complexity when compared to single column
chromatography. Moreover, it lacks the versatility as no
solvent gradient purification can be performed. Notably, the
pressure generated by the SMB system can be significant and
has to be taken into account before integrating it with flow
reactors.
Liquid–liquid extractions is another fundamental
separation strategy in any chemistry reaction. Although
extractions are very common purification strategies also at
industrial scale,37 this process is considered one the most
manually intensive and time/space lab consuming one.
Moreover, the massive use of organic solvents makes it also
unsustainable. It is not surprising, therefore, that significant
efforts have been put into the development of devices to
automatically perform such procedure minimizing the
amount of solvent. Commercially available gadgets (i.e.,
Zaiput liquid–liquid separator) typically rely on a fast mixing
of the immiscible solvents using PTFE tubes and a separation
due to the interactions with a hydrophobic membrane (one
phase will have an affinity for the membrane and fill the
pores – wetting phase – while the other one will be repelled
not filling the pores – non-wetting phase). Once the
membrane pores are filled with the wetting phase, a pressure
differential is applied between the two sides of the
membrane to push the wetting phase without forcing the
non-wetting phase through the pores. They are usually plug-
and-play modular units.
When a flow tandem process is designed, one of the major
considerations is the solvent compatibility between the
different reactions. In an ideal multi-step process, both
solvent and reagent concentration should be kept constant
throughout. In reality, this is almost never the case. Solvent
switching is a very time-consuming procedure and often it
has to be performed by manual intervention stopping the
flow continuous process. Few examples of in-line evaporation
and distillation have been reported,38 and distillation in
particular can allow for both in-line purification, solvent
exchange, and solvent recovery and recycling.
Despite the promising results of flow chemistry
technology, there are still many hurdles to overcome for the
implementation of continuous processes particularly
regarding the handling of solids in flow reactors. One of the
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most important elements to monitor clogging events is the
pressure which increases when suspensions are formed, even
though in an ideal design of a multi-step process,
precipitation should be avoided. Among the common
strategies, flushing the reactor with an appropriate
solubilizing solvent could be an option.39 Alternatively,
sonication while the reagents are flowing through the reactor
can prevent the formation of particulate.40 While a number
of solutions have been developed to manage slurries41 in
continuous mode, these strategies are tailored to specific
systems (some of them are reported in the below section)
and a common technology is not available yet. In a reaction
involving precipitation event, it is necessary to separate the
solid from the liquid phase. There are two possible
outcomes: the collection of the solid (filter cake residue) or
of the liquid (filtrate). In the paper reported by Mascia et al.42
which aims at the collection of the solid for downstream
processing, two different in-line crystallization and filtration
process are performed, both based on low temperature and
vacuum supported devices.
5. Troubleshooting: selected
examples of flow biocatalysis
5.1 Combining enzymes with chemical catalysts
Although the focus of this review is the use of biocatalysis in
flow, continuous techniques can take advantage of typical
catalysts too. When combining both chemical and
biocatalysts the main challenge is to find conditions that
satisfy both requirements. While enzymes normally prefer
aqueous environments, most chemicals are incompatible
with this solvent and not always intermediate conditions are
compatible due to poisoning or deactivation of one of the
catalysts.
One of the options to surpass these limitations is the use
of enzymes which do not suffer inactivation in organic
solvents, either tailoring them to be used in such
conditions43 or taking advantage of their intrinsic
characteristics.44 The perfect example of such biocatalysts are
lipases. While in aqueous media lipases catalyze the cleavage
of ester or amide bonds, in organic solvents they can catalyze
the opposite reaction.
For example, Farkas et al. in 201845 overcame the
limitation of typical dynamic kinetic resolutions of amines
combining the acylation of the racemic starting material via
a stereo-selective enzymatic reaction with the racemization of
the remaining enantiomer through a palladium-based
catalyst in 2-methyl-2-butanol (Fig. 4). The authors developed
a system using a commercially available sol–gel encapsulated
version of Candida antarctica lipase B (CALB-TDP-10) which
showed selectivity for the (S)-enantiomer of the benzylic
amines. After the first conversion, the palladium catalyst is
used to interconvert the remaining (R) enantiomer into the
(S) which is in turn acetylated by the enzyme present in the
same packed bed reactor with excellent yields (67–96%) and
enantiopurity (>99%) for at least three of the tested amines.
Another option to combine both strategies is the
compartmentalization, operating each reactor at different
conditions taking advantage of the modularity of flow
machines. This strategy was applied by Sperl et al.,46 in 2016
for the synthesis of 2-keto-3-deoxy sugar acids (Fig. 4). In
their work, implementing a fed-batch continuous flow hybrid
process, the incompatibility between gold catalyzed sugar
oxidation with enzymatic dehydration could be surpassed.
This is also an excellent example of the step-by-step process
optimization, solving issues that might appear during the
process assembly, such as pH incompatibility or side-product
removal. In their case, removal of hydrogen peroxide from
the gold-catalyzed oxidation was key to ensure the correct
operation of the immobilized dihydroxy acid dehydrogenase
(SsDDH). Continuous operation of their system over 100 mL
resulted in very good yields (69–91%) and good recovered
yields after purification for two of the tested sugars (58 and
86%).
5.2 Overcoming insolubility in flow
Flow biocatalysis cannot be regarded as a simple translation
of the batch reactions in continuous. Most of the times, the
reaction conditions and design have to be optimized when
translated into continuous.
In this sense, in the work of Farkas et al. (Fig. 4), a very
common issue in flow had to be addressed: substrate
insolubility. Previous attempts to perform similar strategies
in flow faced a critical problem as ammonium formate, while
necessary to avoid side reactions in the racemization, was
insoluble in such solvents. This is one of the major problems
when working in continuous flow and, if it cannot be solved,
often imposes the use of semi-continuous approaches (with
intermediate filtrations) to avoid system clogging, detected
specially by an increase on the back pressure of the system.
In their work, the change of solvent to 2-methyl-2-butanol
avoided the precipitation of the ammonium formate.
Fig. 4 Schematic representation of chemoenzymatic dynamic
resolution of benzylic amines developed by Farkas et al. and the fed-
batch continuous approach for the chemo enzymatic synthesis of
2-keto-3-deoxy sugar acids by Sperl et al.
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In other cases, the solvent choice is not so broad as
most enzymes do not perform well in non-aqueous media.
Even if peristaltic pumps are suitable to pump slurry
solutions into the reactor, normally, poor solubility
decreases the efficiency of the process. To prevent it, the
use of surfactants to increase the water solubility of organic
molecules ensure an efficient mass transfer in the reactor,
but bear in mind that they can also have an effect on the
enzymatic preparation.47
Related to this and especially in microfluidic systems, if
protein leakage occurs during operation due to reversible
immobilization techniques or the presence of multimeric
enzymes, the denatured protein can also cause a block. In
this case, it would normally be a good idea to set up regular
washes with cleaning solutions (such as NaOH 1 M or
guanidinium chloride 4 M) to ensure the denature protein
does not have a negative effect on the system.
5.3 The impact of biocatalysis and flow facilities on
sustainability: a self-sustaining closed-loop continuous
reaction
Despite the benefits of biocatalytic processes in flow chemistry
reactors listed above, their application on large scale poses a
significant challenge regarding the recovery of the main solvent:
water.48 Common methodologies such as distillation and ultra-
filtration are not economically-feasible49 and are energy and
time consuming. Moreover, the solvents collected downstream
of the process typically contain traces of unreacted reagents,
side-products or additives that are usually discarded, deeply
impacting on the economy of the system. An excellent example
about a zero-waste reaction was described by Contente &
Paradisi, in 2018.24 The multi-enzymatic process was firstly
improved with respect to batch methods by using catalytic
amounts of cofactors and applied for the synthesis of valuable
products as hydroxytyrosol from commercially available amines
at 10 mM scale. The system was further implemented with in-
line work-up and purification steps making it fully automated.
The major leap forward was represented by the design of a
closed-loop reaction for the recovery of both by-products and
cofactors (Fig. 5).
Standard reactions have been used to prove the feasibility
and the efficiency of the system. The ultra-efficiency concept
reported here for the first time, was achieved using trapping
columns downstream the process to separate the pure
products and the benign by-products (at the end also these
ones recovered through a catch and release strategy). The
partially purified waste waters containing the cofactors in
catalytic amounts have been extensively recirculated allowing
the obtainment of a closed-loop system virtually generating
no waste.
5.4 Pressurized flow reactors: free versus immobilized
enzymes
Oxygen (O2) is a powerful oxidant required in many
biocatalytic processes, however, its low solubility in aqueous
phase restricts its application in flow (bio)reactors. The
application of a gas–liquid segmented flow can be used to
increase the O2 transfer from the gas to the liquid phase. By
increasing the gas flow rate, various flow regimes (from the
slowest to the fastest: bubble, slag and annular flow) are
achieved for the gas–liquid mixing.50 When free enzymes are
the catalysts, tube-in-tube reactors may be operated by
flowing the enzymes and substrates in the inner tube (liquid
phase) that is separated by a membrane from the outer tube
(gas phase). Unfortunately, the two-phase strategies may
cause denaturation of enzymes in the gas–liquid interface,
especially of free enzymes.
Pressurized flow-reactors are an attractive alternative that
facilitates automation and intensification of oxidative flow-
biocatalytic processes while protecting the enzymes against
denaturing contact. The pressurized flow (bio)reactor (≤34
bar) can be operated in a single liquid phase because the
gas–liquid O2 transfer is decoupled in space and time from
the O2-dependent biocatalytic reaction (Fig. 6).
51 In case that
free enzymes are employed, the gas delivery (1–10 mL min−1)
is firstly adjusted by a mass-flow controller until it mixes with
the substrate (Fig. 6A). Then, the free enzymes can be
Fig. 5 Multi-enzymatic closed-loop reaction.
Fig. 6 Flow biocatalysis using pressurized reactors for the O2 supply.
(A) Free enzymes. (B) Packed-bed reactor with co-immobilized
enzymes (GOX: glucose oxidase; CAT: catalase).
Fig. 7 Transamination in a microflow reactor containing surface
immobilized enzymes.
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pumped (0.1–0.4 mL min−1) for mixing with the substrate-O2
flow. Finally, the reaction happens in a coiled reactor whose
input and out pressure are controlled. This system proved an
increase of up to 6-fold on the reaction rate.51 Moreover,
immobilized enzymes can be integrated into the pressurized
flow-reactors (Fig. 6B). In this case, substrates and O2 are
mixed and pumped to the PBR where the enzymatic reaction
happens (Fig. 6B). As one may expect expected, TON, catalyst
productivity and STY of the PBR are superior to the liquid
reactor operated with free enzymes.
5.5 Microfluidics and modelling as reactor engineering tools
Microfluidics enable the miniaturization, integration and
automation of biotransformations while maintaining benefits
like increased reaction rates, large surface-to-volume ratios,
and reduced process costs due to the little volumes needed.52
For these reasons, microfluidic reactors may be preferred for
instance, to carry out screenings, and to produce
pharmaceuticals that are demanded in small scale (i.e.
personalized drugs). The microreactor device is typically a
few centimeters size containing micro-tubing in which the
reaction will happen. 3D-printing is an innovative tool that
allows to shape microreactors on-demand as required by the
reaction conditions.53
Mathematical modelling is a powerful prediction tool for
reactor/reaction engineering.54 A quick optimization and
assessment of a complex flow bioreactor can be performed in
a short period of time. Then, the mathematical model is
experimentally evaluated, usually in combination with
microfluidics. As an example, Miložič et al.55 utilized
mathematical models to facilitate the description of
convective and diffusion mass transfer in a flow reaction
kinetics. The model was tested for the microfluidic reaction
where a ω-transaminase was immobilized on the inner
microreactor walls by ionic interactions (Fig. 7). The
substrate solution was pumped (2–32 μL min−1) to the
silicon/glass microreactor and the resulting product mixture
was diluted with NaOH for further in-line analysis by HPLC.
Microfluidic enabled to test various inlet substrates, enzyme
concentrations, and residence times to verify the proposed
models. Finally, the experimental data can validate the
mathematical models for the biotransformation processes
even within consecutively connected microreactors.
Noteworthy, automation of biocatalytic processes is one of
the main advantages of its integration in flow systems. In
this sense, machine learning for self-optimization of
processes must be taken into consideration for both flow
chemistry56 and enzyme engineering.57 Although the
application of machine learning for flow biocatalysis is still
in its infancy.
5.6 How to meet industrial demands? An example of multi-
gram scale production
While scale up of flow reactions is generally easier than
batch, many processes have been reported as a proof of
concept, with low substrate concentration and productivity,
clearly highlighting a gap between the lab scale and the
industrial demand. A very good example of high productivity
is represented by the biosynthesis of a commercially relevant
product on a multi-gram scale via an intensified process in
flow reported by Contente, et al.,58 in 2019.
As it can be seen in Fig. 8, via a single step enzymatic
transformation using Mycobacterium smegmatis acyl
transferase (MsAcT), melatonin could be synthesized from
5-methoxy tryptamine among others. In this example, the
enzyme was covalently immobilized onto glyoxyl-agarose
beads with a loading of only 1 mg of enzyme per g of resin,
dramatically increasing the catalyst stability. The
chemoselectivity of the enzyme as well as the absence of
hydrolysis side reaction due to the flow mode prevented the
formation of any by-products obtaining the desired amide
with a very high purity. Moreover, the molar conversions
observed were good with ethyl acetate (>60%) but have been
further improved using a more activated acyl donor such as
vinyl acetate (>90%).
In this case, particular attention must be paid on the
substrate loading: the amine was supplied at a concentration
of 0.5 M (95 g L−1) through a liquid–liquid segmented flow.
That means that the amine was dissolved in aqueous
solution while the acetyl donors, were added via a T junction
creating a biphasic stream to the column. The residence time
in this case was only 5 minutes, exemplifying the shortened
reaction times that can be achieved in flow due to the
increased mass transfer and control over the reaction
conditions. To exemplify the extraordinary productivity, the
system was left running for 24 h with the automated work-up
described below with isolated yields up to 36.9 g.
Apart from its very high productivity, the system was
designed to be as efficient as possible. Not only the space–
time yield and atom economy were excellent, but also
through an in-line separation, the ethyl acetate containing
the final product was evaporated, condensed and recirculated
yielding the pure N-acetyl molecules. As reported above, also
the aqueous phase with the unreacted amine was recovered
and reused. In this way, the reaction has negligible waste
contribution, excellent atom economy and ensures no loss of
substrate or organic solvent.
6. Conclusions
Global climate change made us aware that a more
sustainable way of working and living is necessary. The
Fig. 8 Schematic representation of production of melatonin.
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innovative combination of biocatalysis and flow chemistry
facilities has the power to address this requirement. Flow
biocatalysis with its efficient and eco-friendly production of
various organic molecules applicable to food, cosmetic,
chemical and pharmaceutical industry is promoting green
chemistry with a significant economic and environmental
impact on the society.
This tutorial review outlines how biocatalytic processes are
dramatically improved by continuous flow technology
fulfilling also industrial needs such as short reaction times,
increased performance and productivity. Key concepts and
detailed definitions, the “corner stone” of flow biocatalysis,
have been described. In addition, to help newcomers to the
field, the main challenges are discussed, and practical
specific solutions are presented.
Although flow biocatalysis may be considered at an early
stage of its development, we feel that there is a bright future,
especially for multi-enzymatic cascade reactions, overcoming
the market, regulatory, technical, and cultural barriers for its
implementation.
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